Raquel S. Jallad

Treatment of acromegaly with octreotide‐LAR: extensive experience in a Brazilian institution

Raquel S. Jallad, Nina Rosa de Castro Musolino, L R Salgado et al. · Clinical Endocrinology · 2005 · 87 citations

Acromegaly: correlation between expression of somatostatin receptor subtypes and response to octreotide-lar treatment

A Casarini, Raquel S. Jallad, Emília M. Pinto et al. · Pituitary · 2009 · 77 citations

Octreotide-lar Treatment, Allergy, Somatostatin Receptor Subtypes +4

Does partial surgical tumour removal influence the response to octreotide‐LAR in acromegalic patients previously resistant to the somatostatin analogue?

Raquel S. Jallad, Nina Rosa de Castro Musolino, Sérgio Keidi Kodaira et al. · Clinical Endocrinology · 2007 · 65 citations

Optimizing Medical Therapy of Acromegaly: Beneficial Effects of Cabergoline in Patients Uncontrolled with Long-Acting Release Octreotide

Raquel S. Jallad, Marcello D. Bronstein · Neuroendocrinology · 2009 · 59 citations

Pharmacokinetic profile of lanreotide Autogel^® in patients with acromegaly after four deep subcutaneous injections of 60, 90 or 120 mg every 28 days

Marcello D. Bronstein, Nina Rosa de Castro Musolino, Raquel S. Jallad et al. · Clinical Endocrinology · 2005 · 54 citations

Therapeutic Drug Monitoring, Translational Medicine, Subcutaneous Injections +12